Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study

Autor: Chanchlani, N, Lin, S, Auth, MK, Lee, CL, Robbins, H, Looi, S, Murugesan, SV, Riley, T, Preston, C, Stephenson, S, Cardozo, W, Sonwalkar, SA, Allah-Ditta, M, Mansfield, L, Durai, D, Baker, M, London, I, London, E, Gupta, S, Di Mambro, A, Murphy, A, Gaynor, E, Jones, KDJ, Claridge, A, Sebastian, S, Ramachandran, S, Selinger, CP, Borg-Bartolo, SP, Knight, P, Sprakes, MB, Burton, J, Kane, P, Lupton, S, Fletcher, A, Gaya, DR, Colbert, R, Seenan, JP, MacDonald, J, Lynch, L, McLachlan, I, Shields, S, Hansen, R, Gervais, L, Jere, M, Akhtar, M, Black, K, Henderson, P, Russell, RK, Lees, CW, Derikx, LAAP, Lockett, M, Betteridge, F, De Silva, A, Hussenbux, A, Beckly, J, Bendall, O, Hart, JW, Thomas, A, Hamilton, B, Gordon, C, Chee, D, McDonald, TJ, Nice, R, Parkinson, M, Gardner-Thorpe, H, Butterworth, JR, Javed, A, Al-Shakhshir, S, Yadagiri, R, Maher, S, Pollok, RCG, Ng, T, Appiahene, P, Donovan, F, Lok, J, Chandy, R, Jagdish, R, Baig, D, Mahmood, Z, Marsh, L, Moss, A, Abdulgader, A, Kitchin, A, Walker, GJ, George, B, Lim, Y-H, Gulliver, J, Bloom, S, Theaker, H, Carlson, S, Cummings, JRF, Livingstone, R, Beale, A, Carter, JO, Bell, A, Coulter, A, Snook, J, Stone, H, Kennedy, NA, Goodhand, JR, Ahmad, T, IMSAT study investigators

BACKGROUND: Anti-drug antibodies are associated with treatment failure to anti-TNF agents in patients with inflammatory bowel disease (IBD). AIM: To assess whether immunogenicity to a patient's first anti-TNF agent would be associated with immunogeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::39d735bb09a4a7716e305b56c8e08c0b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P112 Impact of therapeutic drug monitoring on outcomes for patients with inflammatory bowel disease

Autor: Rebecca Stearns, Nishant Patodi, Tanya Chopra, Aminda De Silva, Arif Hussenbux, Rahul Ravindran

Publikováno v: Posters.

Introduction Anti-tumour necrosis factor α biological drugs have proven efficacy in the management of inflammatory bowel disease (IBD). Among infliximab and adalimumab treated cohorts, primary non response occurs in up to 30% and secondary non respo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89ad9db1f0b465d088baae39a45bd717
https://doi.org/10.1136/gutjnl-2020-bsgcampus.187

Steroids in inflammatory bowel disease: a clinical review.

Autor: Hussenbux, Arif, De Silva, Aminda

Publikováno v: Journal of Prescribing Practice; Mar2021, Vol. 3 Issue 3, p107-111, 5p

Statin-induced necrotizing autoimmune myopathy: importance of early recognition

Autor: Monika Hofer, Alan Steuer, Arif Hussenbux

Publikováno v: British Journal of Hospital Medicine. 78:352-353

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333ba893dfa7eaf76961cb633c8af6e3
https://doi.org/10.12968/hmed.2017.78.6.352